| Financial Year |
March 31 2023 |
| Monetary Funds |
259,869,771.24 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,681,269.01 |
| Accounts Receivable |
311,344,254.48 |
| Advances to Suppliers |
8,062,890.63 |
| Other Receivables |
73,798,133.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
84,011,443.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,241,858.03 |
| Other Current Assets |
16,950,054.82 |
| Total Current Assets |
1,064,503,351.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,856,748.24 |
| Long-term Equity Investment |
61,986,129.71 |
| Investment Properties |
60,882,660.78 |
| Fixed Assetes |
99,513,876.04 |
| Under-construction Projects |
4,669,362.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,605,023.99 |
| R&D expenses |
49,879,454.69 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,517,112.50 |
| Deferred Income Tax Assets |
71,598,223.57 |
| Other Non-Current Assets |
3,089,165.25 |
| Sub-Total of Non-Current Assets |
424,074,439.75 |
| Total Assets |
1,488,577,791.32 |
| Short-Term Loans |
135,931,153.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,782,262.40 |
| Accounts Payable |
508,638,621.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,447,925.51 |
| Taxes Payable |
3,448,937.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
72,806,811.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,996,439.08 |
| Other Current Liabilities |
44,740,523.42 |
| Sub-Total of Current Liabilities |
886,723,700.60 |
| Long-term Loans |
19,136,250.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,994,101.45 |
| Total Liabilities |
906,717,802.05 |
| Paid-In Capital(Or Share Stock) |
712,153,001.00 |
| Capital Surplus |
226,848,974.83 |
| Surplus Reserve |
29,604,517.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-544,848,893.05 |
| Minority Stockholder's Interest |
158,102,389.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
423,757,599.91 |
| Owner's Equity（Stockholder's Equity） |
581,859,989.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,488,577,791.32 |
